Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biodelivery Sci Intl (BDSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 87,680
  • Shares Outstanding, K 54,800
  • Annual Sales, $ 15,550 K
  • Annual Income, $ -67,140 K
  • 36-Month Beta 0.98
  • Price/Sales 5.82
  • Price/Cash Flow 0.00
  • Price/Book 0.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.55 +3.23%
on 04/19/17
2.10 -23.81%
on 03/31/17
-0.30 (-15.79%)
since 03/21/17
3-Month
1.55 +3.23%
on 04/19/17
2.15 -25.58%
on 03/10/17
-0.30 (-15.79%)
since 01/20/17
52-Week
1.50 +6.67%
on 11/23/16
3.78 -57.67%
on 04/26/16
-2.09 (-56.64%)
since 04/21/16

Most Recent Stories

More News
BioDelivery (BDSI) Down 15% Since Earnings Report: Can It Rebound?

BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BDSI : 1.60 (-3.03%)
BioDelivery to Grant New Patents for its Marketed Drugs

BioDelivery Sciences (BDSI) recently announced its decision to grant two new patents to extend the patent life for all three of its marketed products, Belbuca , Bunavail, and Onsolis.

HSKA : 105.17 (+0.42%)
COL : 104.70 (+5.13%)
BDSI : 1.60 (-3.03%)
RTRX : 18.47 (-1.96%)
BioDelivery Sciences International and Rexahn Pharmaceuticals See Share Values Rise Slightly

NEW YORK, NY / ACCESSWIRE / March 28, 2017 / These two stocks posted gains on Monday as they are likely to reduce losses going ahead. Both companies also moved forward with the FDA trials as their lead...

BDSI : 1.60 (-3.03%)
Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma

On Thursday, March 23, 2017, the NASDAQ Composite ended the trading session at 5,817.69, down 0.07%; the Dow Jones Industrial Average edged 0.02% lower, to finish at 20,656.58; and the S&P 500 closed at...

BNTC : 2.64 (+0.76%)
BDSI : 1.60 (-3.03%)
SAGE : 72.82 (+1.66%)
OGXI : 0.37 (+2.78%)
BNIKF : 0.1470 (+13.08%)
BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet

BioDelivery Sciences International, Inc. (BDSI) reported loss of 29 cents per share in the fourth quarter of 2016, slightly wider than the Zacks Consensus Estimate of a loss of 28 cents.

ABCO : 47.50 (unch)
ENDP : 10.29 (-1.81%)
BDSI : 1.60 (-3.03%)
ADUS : 32.80 (+0.92%)
BioDelivery Q4 Loss Wider Than Expected; Revenues in Line

BioDelivery???s fourth-quarter 2016 loss of 29 cents per share is slightly wider than consensus estimates of 28 cents per share.

BDSI : 1.60 (-3.03%)
BioDelivery Sciences Announces Three Data Presentations on BELBUCA® at the American Academy of Pain Medicine 33rd Annual Meeting

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced three data presentations from research surrounding BELBUCA® (buprenorphine) buccal film (CIII) at the American Academy of Pain Medicine...

BDSI : 1.60 (-3.03%)
BioDelivery Sciences to Host Conference Call and Webcast Reporting Fourth Quarter and Full-Year 2016 Financial Results on Friday, March 17

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it will report its fourth quarter and full-year 2016 financial results and host a conference call and webcast at 8:00 AM Eastern Time...

BDSI : 1.60 (-3.03%)
BioDelivery (BDSI): What's in Store this Earnings Season?

BioDelivery Sciences International, Inc. (BDSI) is expected to report fourth-quarter 2016 results on Mar 17, before the opening bell. Last quarter, the company???s loss was wider than expected.

BDSI : 1.60 (-3.03%)
BMRN : 88.47 (-1.95%)
ABBV : 63.82 (+0.06%)
BIIB : 272.94 (+0.18%)
BioDelivery Sciences Secures Debt Financing with CRG

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that it has entered into a senior credit facility with affiliates of CRG LP, a healthcare-focused investment firm, to retire its...

BDSI : 1.60 (-3.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Support & Resistance

2nd Resistance Point 1.73
1st Resistance Point 1.67
Last Price 1.60
1st Support Level 1.57
2nd Support Level 1.53

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.